Skip to main content

TVP23A Antibody [FITC]

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-98146F

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-98146F

Key Product Details

Species Reactivity

Human

Applications

Immunocytochemistry/ Immunofluorescence

Label

FITC (Excitation = 495 nm, Emission = 519 nm)

Antibody Source

Polyclonal Rabbit IgG

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

Produced in rabbits immunized with E. coli-derived Human TVP23A fragment.

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Applications for TVP23A Antibody [FITC]

Application
Recommended Usage

Immunocytochemistry/ Immunofluorescence

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Antigen and protein A Affinity-purified

Formulation

PBS

Preservative

0.05% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C in the dark.

Background: TVP23A

Alternate Names

FAM18A, Family With Sequence Similarity 18, Member A, Golgi Apparatus Membrane Protein TVP23 Homolog A, Protein FAM18A, Trans-Golgi Network Vesicle Protein 23 Homolog A (S. Cerevisiae), YDR084C

Gene Symbol

TVP23A

Additional TVP23A Products

Product Documents for TVP23A Antibody [FITC]

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for TVP23A Antibody [FITC]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...